In 2015, Barry and Joy Lambert made an unprecedented donation of $33.7 million to the University of Sydney for research into the therapeutic use of medicinal cannabis. This resulted in the Lambert Initiative.
The Lambert initiative is an Australian first in the field of medicinal cannabinoids – both in its breadth and depth of research innovation.
We are targeting a range of conditions including paediatric epilepsy, cancer, chronic pain, obesity, neurological, and mental health disorders.
Our approach involves using medicinal chemistry, cellular and preclinical research, early human testing and clinical trials in patients to identify and develop novel cannabinoid-based therapeutics.
We are also translating research outcomes into practice by providing outreach to the community and to health professionals, and engaging consumer organisations and media to educate the public and transform current policy.
Our aim is to optimise and introduce safe and effective cannabinoid therapeutics into mainstream medicine in Australia and beyond.
Welcome to the Lambert Initiative. Join us in the voyage of discovery.
Access to medicinal cannabis involves a much more complicated process than with most other medicines. A doctor must either be an 'Authorised Prescriber' or be prepared to make an application on behalf of their patient through the TGA 'Special Access Scheme'.
Our research focus is to unlock the therapeutic potential of plant-derived cannabinoids and full-spectrum cannabis extracts. More than 15 foundation projects are currently being funded and novel findings are being produced.
Discover the fundamentals of medicinal cannabis and cannabinoid therapeutics, including key definitions, a brief history, and how the Lambert Initiative is unlocking the medical and health benefits of this amazing plant.
The University of Sydney and Thomas Jefferson University have officially agreed to collaborate on education and research on the therapeutic uses of cannabinoids.
Australians with epilepsy are turning to cannabis products when antiepileptic drug side-effects are intolerable and epilepsy uncontrolled.